Fifty-two patients with PCOS were randomized in two groups : group A ( n = @ ) received @ mg ethinyl estradiol + @ mg cyproterone acetate and group B ( n = @ ) received @ mg ethinyl estradiol + @ mg drospirenone-containing OCs for @ months .